XtalPi
Focus: XtalPi is a China-based AI drug design company leveraging computational chemistry and robotics to accelerate drug discovery, particularly in neurology and ophthalmology. The company is publicly listed and recently forecasted its first full-year profit in 2025.
Profile data last refreshed 17h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
0
About XtalPi
AI assessmentNot HiringNo open roles listed right now. Follow XtalPi to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for XtalPi
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.